On March 17, Shen Wanlingxin CSI R&D Innovation 100 Exchange-traded Open-ended Index (515200) closed down 0.66%, with a turnover of 1.0826 million yuan.
Innovation 100 ETF (515200) was established on October 25, 2019, and the full name of the fund is Shenwan Lingxin CSI R&D Innovation 100 Exchange-traded Open-ended Index Securities Investment Fund, and the fund is referred to as Shenwan Lingxin CSI R&D Innovation 100 Exchange-traded Open-ended Index. The fund has a management fee of 0.50% per annum and a custody fee of 0.10% per annum. The performance of the Innovation 100 ETF (515200) is based on the CSI R&D Innovation 100 Index.
In terms of scale, as of March 14, the latest share of Innovation 100 ETF (515200) was 105 million shares, and the latest scale was 174 million yuan. Looking back on December 31, 2024, the share of Innovation 100 ETF (515200) was 111 million shares, and the scale was 168 million yuan. That is, the share of the fund has decreased by 5.41% since the beginning of this year, and the scale has increased by 3.46%.
In terms of liquidity, as of March 17, the cumulative turnover of Innovation 100 ETF (515200) in the past 20 trading days was 72.1849 million yuan, with an average daily turnover of 3.6092 million yuan, and since the beginning of this year, the cumulative turnover in 47 trading days has been 156 million yuan, with an average daily turnover of 3.3214 million yuan.
The current fund manager of Innovation 100 ETF (515200) is Wang Yunjie. Wang Yunjie has managed (or intends to manage) the fund since July 22, 2020, with a return of 2.35% during his tenure.
According to the latest regular report, the heavy stocks of Innovation 100 ETF (515200) include BYD, Hengrui Pharmaceutical, Mindray Medical, Haiguang Information, ZTE, Inovance Technology, North Huachuang, Hikvision, CRRC, and Guodian NARI, with the following proportions.
| stock symbol | ,stock name | ,position ratio | , number of shares held (shares). | Market value of the position (RMB). |
| 002594 | BYD | 6.12%, | 36,410,288,800||
| 600276 | Hengrui Pharmaceutical | , 4.91%, | 179,78,246,100 | |
| 300760 | Mindray Medical | 3.70% | 24,4622.20 | |
| 688041 | Haiguang Information | 3.33% | 37,45602,100 | |
| 000063 | ZTE | 3.12%, | 129,75239,900 | |
| 300124 | Inovance Technology | 3.02%, | 86,75,076,200 | |
| 002371 | North Huachuang | 2.98%, | 12,805,011,800||
| 002415 | Hikvision | 2.71%, | 148,64,561,800 | |
| 601766 | CRRC | 2.44%, | 489,500, | 102,000 |
| 600406 | NARI | 2.43%, | 161,7407.70 |
Risk Warning: The market is risky, and investment needs to be cautious. This article is automatically released by the AI model, and any information appearing in this article (including but not limited to individual stocks, comments, forecasts, charts, indicators, theories, any form of expression, etc.) is for reference only and does not constitute personal investment advice. The MACD golden cross signal is formed, and these stocks are rising well!
Ticker Name
Percentage Change
Inclusion Date
